Cargando…
Tumor analysis: freeze–thawing cycle of triple-negative breast cancer cells alters tumor CD24/CD44 profiles and the percentage of tumor-infiltrating immune cells
OBJECTIVE: The use of novel methods to characterize living tumor cells relies on well-conceived biobanks. Herein, we raised the question of whether the composition of fresh and freeze/thawed dissociated tumor samples is comparable in terms of quantitative and qualitative profiling. RESULTS: Breast c...
Autores principales: | Le Gallo, Matthieu, de la Motte Rouge, Thibault, Poissonnier, Amanda, Lavoué, Vincent, Tas, Patrick, Leveque, Jean, Godey, Florence, Legembre, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011598/ https://www.ncbi.nlm.nih.gov/pubmed/29925435 http://dx.doi.org/10.1186/s13104-018-3504-5 |
Ejemplares similares
-
CD95/Fas, Non-Apoptotic Signaling Pathways, and Kinases
por: Le Gallo, Matthieu, et al.
Publicado: (2017) -
CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cells
por: Qadir, Abdul S., et al.
Publicado: (2021) -
CD44 enhances tumor aggressiveness by promoting tumor cell plasticity
por: Paulis, Yvette W.J., et al.
Publicado: (2015) -
CD44 as a potential diagnostic tumor marker
por: Basakran, Nawwaf S.
Publicado: (2015) -
CD44 as a tumor biomarker and therapeutic target
por: Xu, Hanxiao, et al.
Publicado: (2020)